HomeTagsHansa Biopharma

Hansa Biopharma

Biotechnology

Hansa Biopharma Announces $70 Million Non-dilutive Product Finance Transaction With Novaquest

PR Newswire - July 20, 2022

Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...

Biotechnology

NICE Recommends Use of Hansa Biopharma’s Idefirix As Desensitization Treatment

PR Newswire - June 16, 2022

Hansa Biopharma, "Hansa", pioneer in enzyme technology for rare immunological conditions, announces the recommendation by the National Institute for Health and Care Excellence (NICE)...